Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum beta-Lactamase-Producing Escherichia coli Bacteremia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Yoon Soo | - |
dc.contributor.author | Bae, Il Kwon | - |
dc.contributor.author | Kim, Juwon | - |
dc.contributor.author | Jeong, Seok Noon | - |
dc.contributor.author | Hwang, Seung-sik | - |
dc.contributor.author | Seo, Yiel-Hea | - |
dc.contributor.author | Cho, Yong Kyun | - |
dc.contributor.author | Lee, Kyungwon | - |
dc.contributor.author | Kim, June Myung | - |
dc.date.available | 2020-02-28T17:46:47Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2014-03-01 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/12790 | - |
dc.description.abstract | Purpose: Inadequate empirical therapy for severe infections caused by extended-spectrum beta-lactamase-producing Escherichia coli (ESBLEC) is associated with poor outcomes. This study was designed to investigate risk factors for community-onset ESBLEC bacteremia at admission to a tertiary care hospital. Materials and Methods: A case-control study was performed that included all episodes of ESBLEC bacteremia in the outpatient department or within 48 hours of admission from January 2005 to March 2009. Data on predisposing factors were collected. The molecular epidemiology of ESBLEC clinical isolates was also determined. Results: Among 25281 blood cultures, 60 episodes of ESBLEC bacteremia were studied, which accounted for 7% of all E. coli bacteremia at admission. Healthcare-associated infection [odds ratio (OR), 8.3; 95% confidence interval (CI), 2.4-28.7; p=0.001], malignancy (OR, 4.6; 95% CI, 1.3-16.3; p=0.018), urinary tract infection (OR, 139.1; 95% CI, 24.6-788.2; p<0.001), hepatobiliary infection (OR, 79.1; 95% CI, 13.5-463.8; p<0.001), third generation cephalosporin usage during preceding 3 months (OR, 16.4; 95% CI, 2.0-131.8; p=0.008), and severe sepsis/septic shock (OR, 73.7; 95% CI, 12.4-438.5; p<0.001) were determined as independent risk factors for community-onset ES-BLEC bacteremia. The most common extended-spectrum beta-lactamase (ESBL) gene identified was blaCTX-M-15 (n=31) followed by blaCTX-M-14 (n=23). Conclusion: The most common types of ESBLs in E. coli causing community-onset bacteremia were CTX-M-15 and CTX-M-14 in Korea. By result of decision tree analysis, the empirical use of carbapenems is suggested only for patients with severe sepsis/septic shock, hepatobiliary infection, or healthcare-associated urinary tract infection. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | YONSEI UNIV COLL MEDICINE | - |
dc.relation.isPartOf | YONSEI MEDICAL JOURNAL | - |
dc.subject | BLOOD-STREAM INFECTIONS | - |
dc.subject | INITIAL ANTIMICROBIAL THERAPY | - |
dc.subject | KLEBSIELLA-PNEUMONIAE | - |
dc.subject | DECISION-TREE | - |
dc.subject | ENTEROBACTERIACEAE | - |
dc.subject | MORTALITY | - |
dc.subject | EMERGENCE | - |
dc.subject | CLASSIFICATION | - |
dc.subject | RESISTANCE | - |
dc.subject | IMPACT | - |
dc.title | Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum beta-Lactamase-Producing Escherichia coli Bacteremia | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000331916800026 | - |
dc.identifier.doi | 10.3349/ymj.2014.55.2.467 | - |
dc.identifier.bibliographicCitation | YONSEI MEDICAL JOURNAL, v.55, no.2, pp.467 - 475 | - |
dc.identifier.kciid | ART001851894 | - |
dc.identifier.scopusid | 2-s2.0-84894228728 | - |
dc.citation.endPage | 475 | - |
dc.citation.startPage | 467 | - |
dc.citation.title | YONSEI MEDICAL JOURNAL | - |
dc.citation.volume | 55 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Park, Yoon Soo | - |
dc.contributor.affiliatedAuthor | Seo, Yiel-Hea | - |
dc.contributor.affiliatedAuthor | Cho, Yong Kyun | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Risk factors | - |
dc.subject.keywordAuthor | beta-lactamase | - |
dc.subject.keywordAuthor | Escherichia coli | - |
dc.subject.keywordAuthor | CTX-M | - |
dc.subject.keywordPlus | BLOOD-STREAM INFECTIONS | - |
dc.subject.keywordPlus | INITIAL ANTIMICROBIAL THERAPY | - |
dc.subject.keywordPlus | KLEBSIELLA-PNEUMONIAE | - |
dc.subject.keywordPlus | DECISION-TREE | - |
dc.subject.keywordPlus | ENTEROBACTERIACEAE | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | EMERGENCE | - |
dc.subject.keywordPlus | CLASSIFICATION | - |
dc.subject.keywordPlus | RESISTANCE | - |
dc.subject.keywordPlus | IMPACT | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.